Slump in medtech VC activity continues as inflation keeps investors on the sidelines

Slump in medtech VC activity continues as inflation keeps investors on the sidelines

Source: 
BioPharma Dive
snippet: 
  • The value of medtech venture capital deals fell 40% year-over-year in the first quarter, according to financial data provider PitchBook.
  • Investors struck deals worth $1.8 billion over the first three months of 2023, down from $3.0 billion across the start of 2022.